Rx-04 series

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRx-04 series
Drug Alias NameAntibacterials (Rib-X/Sanofi)RX-1316RX-B163RX-I338RX-I98 +[33] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial proteins synthesis inhibitors
TargetsBacterial proteins
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMelinta Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMelinta Therapeutics LLCSanofi
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A